A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
The EMPEROR-Preserved trial compared the efficacy and safety of empagliflozin with placebo in adults with heart failure and preserved ejection fraction, with and without diabetes.
Avoiding unnecessary medications in CKD might reduce the risks for adverse outcomes, investigators suggested.
For each 1-degree Celsius increase in daily mean temperature, estimated risk for hospitalization for renal diseases increased by 0.9%
Associations identified for glycochenodeoxycholate, O-methylcatechol sulfate, and 3-methyl catechol sulfate
In cohort of individuals with diabetes, no association seen for chronic kidney disease stage 3 to 5 with atopic eczema, psoriasis
In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
Metabolic acidosis was defined as serum bicarbonate values of 12 or higher but less than 22 mEq/L.
Multimorbidity is more common in patients with chronic kidney disease (CKD) than any other long-term condition, according to investigators.
Patients who survive the first 30 days of COVID-19 are more likely to have acute kidney injury and chronic kidney disease compared with those who do not contract the disease.